Reper­toire inks au­toim­mune deal with Genen­tech as it eyes a re­turn to the clin­ic

Every few years, Reper­toire Im­mune Med­i­cines makes a ma­jor an­nounce­ment in April. And this year is no dif­fer­ent.

The Flag­ship Pi­o­neer­ing-in­cu­bat­ed start­up on Wednes­day un­veiled …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER